SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-041192
Filing Date
2021-08-05
Accepted
2021-08-05 07:50:49
Documents
44
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q wve-10q_20210630.htm   iXBRL 10-Q 1625984
2 EX-31.1 wve-ex311_6.htm EX-31.1 16618
3 EX-31.2 wve-ex312_7.htm EX-31.2 16924
4 EX-32 wve-ex32_8.htm EX-32 8848
5 GRAPHIC g1pek4cr343m000001.jpg GRAPHIC 129217
  Complete submission text file 0001564590-21-041192.txt   4194086

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA wve-20210630.xsd EX-101.SCH 29440
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wve-20210630_cal.xml EX-101.CAL 33686
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wve-20210630_def.xml EX-101.DEF 84785
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20210630_lab.xml EX-101.LAB 228717
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20210630_pre.xml EX-101.PRE 161936
11 EXTRACTED XBRL INSTANCE DOCUMENT wve-10q_20210630_htm.xml XML 291042
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37627 | Film No.: 211146377
SIC: 2834 Pharmaceutical Preparations